USFDA pulls up Aurobindo Pharma for manufacturing lapses at API plant, Health News, ET HealthWorld
New Delhi: The US Food and Drug Administration (USFDA) has issued a warning letter to Aurobindo Pharma for violating current good manufacturing practice norms at its Telangana-based plant. In a…

